1. A High Notch Pathway Activation Predicts Response to γ Secretase Inhibitors in Proneural Subtype of Glioma Tumor-Initiating Cells. (3rd January 2014) Authors: Saito, Norihiko; Fu, Jun; Zheng, Siyuan; Yao, Jun; Wang, Shuzhen; Liu, Diane D.; Yuan, Ying; Sulman, Erik P.; Lang, Frederick F.; Colman, Howard; Verhaak, Roel G.; Yung, W. K. Alfred; Koul, Dimpy Journal: Stem cells Issue: Volume 32:Number 1(2014:Jan.) Page Start: 301 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A High Notch Pathway Activation Predicts Response to γ Secretase Inhibitors in Proneural Subtype of Glioma Tumor‐Initiating Cells. (3rd January 2014) Authors: Saito, Norihiko; Fu, Jun; Zheng, Siyuan; Yao, Jun; Wang, Shuzhen; Liu, Diane D.; Yuan, Ying; Sulman, Erik P.; Lang, Frederick F.; Colman, Howard; Verhaak, Roel G.; Yung, W. K. Alfred; Koul, Dimpy Journal: Stem cells Issue: Volume 32:Number 1(2014:Jan.) Page Start: 301 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A High Notch Pathway Activation Predicts Response to γ Secretase Inhibitors in Proneural Subtype of Glioma Tumor‐Initiating Cells. (January 2014) Authors: Saito, Norihiko; Fu, Jun; Zheng, Siyuan; Yao, Jun; Wang, Shuzhen; Liu, Diane D.; Yuan, Ying; Sulman, Erik P.; Lang, Frederick F.; Colman, Howard; Verhaak, Roel G.; Yung, W. K. Alfred; Koul, Dimpy Journal: Stem cells Issue: Volume 32:Number 1(2014:Jan.) Page Start: 301 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Activation of WEE1 confers resistance to PI3K inhibition in glioblastoma. Issue 1 (7th July 2017) Authors: Wu, Shaofang; Wang, Shuzhen; Gao, Feng; Li, Luyuan; Zheng, Siyuan; Yung, W K Alfred; Koul, Dimpy Journal: Neuro-oncology Issue: Volume 20:Issue 1(2018) Page Start: 78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. CBIO-02. AMPLIFIED EGFR DRIVES TUMORIGENESIS IN TP53 WILD TYPE GLIOBLASTOMA THROUGH INHIBITION OF p53 FUNCTION BY DNA-PK/p53 BINDING. (6th November 2017) Authors: Ding, Jie; Li, Xiaolong; Wasylishen, Amanda; Gao, Feng; Zhao, Yang; Baggerly, Keith; Lozano, Guillermina; Koul, Dimpy; Yung, W K Alfred Journal: Neuro-oncology Issue: Volume 19(2017)Supplement 6 Page Start: vi33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. CBMT-32. EGFR SUPPRESSES p53 FUNCTION THROUGH DNA-PKcs BINDING TO p53: NOVEL CROSSTALK BETWEEN EGFR AND TP53 IN GLIOBLASTOMA. (11th November 2019) Authors: Ding, Jie; Li, Xiaolong; Zhang, Chen; Gao, Feng; Wu, Shaofang; Wasylishen, Amanda; Baggerly, Keith; Lozano, Guillermina; Koul, Dimpy; Yung, Alfred Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. CNSC-12. NEURONAL DIFFERENTIATION DRIVES THE ANTI-TUMOR EFFICACY OF MEK INHIBITION IN GLIOBLASTOMA. (14th November 2022) Authors: Khan, Sabbir; Martinez-Ledesma, Emmanuel; Park, Soon Young; Dong, Jianwen; Piao, Yuji; Harrison, Erin; Koul, Dimpy; Balasubramaniyan, Veerakumar; de Groot, John; Yung, W K Alfred Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. DDDR-13. MGMT FUNCTION DETERMINES THE DIFFERENTIAL RESPONSE OF ATR AND PARP INHIBITORS WITH DNA DAMAGING AGENTS FOR GBM THERAPY. (14th November 2022) Authors: Koul, Dimpy; Wu, Shaofang; Li, Xaolong; Khan, Sabbir; Balasubramaniyan, Veerakumar; Yung, W K Alfred Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. DDRE-05. DECREASED EXPRESSION OF DNA DAMAGE RESPONSE PATHWAYS CORRELATES WITH SYNERGISTIC ACTIVITY OF TEMOZOLOMIDE WITH ATR INHIBITORS IN GLIOBLASTOMA. (9th November 2020) Authors: Wu, Shaofang; Li, Xiaolong; Singh, Sanjay; Koul, Dimpy; Yung, W K Alfred Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. DDRE-33. PRECLINICAL THERAPEUTIC EFFICACY OF THE NOVEL BLOOD BRAIN BARRIER PENETRANT ATR INHIBITOR LR02 IN GLIOBLASTOMA. (12th November 2021) Authors: Koul, Dimpy; Balasubramaniyan, Veerakumar; Li, Xiaolong; Khan, Sabbir; Guggi, Davide; Mehrling, Thomas; DeGroot, John Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗